Crossmark

The peripheral blood mononuclear cells versus purified CD34+ cells transplantation in patients with angiitis-induced critical limb ischemia trial: 5-year outcomes and return to work analysis—a randomized single-blinded non-inferiority trial

Crossref DOI link: https://doi.org/10.1186/s13287-022-02804-4

Published Online: 2022-03-21

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Hao

Pan, Tianyue

Liu, Yifan

Fang, Yuan

Fang, Gang

Jiang, Xiaolang

Chen, Bin

Wei, Zheng

Gu, Shiyang

Liu, Peng

Fu, Weiguo

Dong, Zhihui http://orcid.org/0000-0002-3754-2458
Funding

Funding for this research was provided by:

China National Natural Science Funds (81970407, 82000452)

China National Natural Science Funds (81900426)

Shanghai Sailing Program (20YF1406600)

Grants from Shanghai Excellent Academic Leader (19XD1401200)

Fudan University “Star of Tomorrow” Famous Doctor Training Project (2019)
License Information

Text and Data Mining valid from 2022-03-21

Version of Record valid from 2022-03-21
More Information

Article History

Received: 7 February 2022

Accepted: 27 February 2022

First Online: 21 March 2022

Declarations

:

: The study design was approved by the Ethics Committee of Zhongshan Hospital, Fudan University, Shanghai, China. All included patients were informed about the nature of the study and gave their written informed consent.

: All patients signed a consent form for their data to be used for research or publication.

: All authors declare no competing interests.

Document is current

Any future updates will be listed below